Study uncovers factors potentially associated with lower LUTS risk

• by Andrea Surnit

• August 21, 2026

FDA approves gene therapy for MPS IIIA

The one-time intravenous treatment uses adeno-associated virus serotype 9 to deliver a functional copy of the SGSH gene.

• by Kathryn Wighton

• September 18, 2026

• 2 min

Knee sepsis may be rare across tibial fracture care

Investigators documented acute knee sepsis after both intra- and extra-articular nailing of open tibial shaft fractures.

• by Andrea Surnit

• September 23, 2026

• 3 min

The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.

“Doctors rely on this evidence, patients rely on this evidence, and if that evidence is not there, it’s going to lead to a lot of uncertainty."

• by David Hilzenrath

• September 22, 2026

• 14 min